Filter News
Area of Research
- (-) Materials (7)
- (-) Neutron Science (11)
- Biological Systems (1)
- Biology and Environment (16)
- Clean Energy (6)
- Computational Biology (2)
- Computational Engineering (1)
- Fusion and Fission (1)
- Isotopes (5)
- Materials for Computing (2)
- National Security (2)
- Nuclear Science and Technology (2)
- Supercomputing (17)
News Type
News Topics
- (-) Biomedical (17)
- 3-D Printing/Advanced Manufacturing (27)
- Advanced Reactors (5)
- Artificial Intelligence (12)
- Big Data (3)
- Bioenergy (15)
- Biology (9)
- Biotechnology (1)
- Buildings (5)
- Chemical Sciences (33)
- Clean Water (4)
- Climate Change (5)
- Composites (9)
- Computer Science (24)
- Coronavirus (11)
- Critical Materials (13)
- Cybersecurity (5)
- Decarbonization (9)
- Energy Storage (38)
- Environment (21)
- Exascale Computing (2)
- Fossil Energy (1)
- Frontier (4)
- Fusion (8)
- Grid (5)
- High-Performance Computing (6)
- Hydropower (1)
- Irradiation (1)
- Isotopes (13)
- ITER (1)
- Machine Learning (7)
- Materials (80)
- Materials Science (87)
- Mathematics (1)
- Microscopy (27)
- Molten Salt (3)
- Nanotechnology (43)
- National Security (4)
- Net Zero (1)
- Neutron Science (106)
- Nuclear Energy (18)
- Partnerships (11)
- Physics (31)
- Polymers (18)
- Quantum Computing (4)
- Quantum Science (15)
- Renewable Energy (1)
- Security (3)
- Simulation (1)
- Space Exploration (5)
- Summit (6)
- Sustainable Energy (14)
- Transformational Challenge Reactor (3)
- Transportation (19)
Media Contacts
Biological membranes, such as the “walls” of most types of living cells, primarily consist of a double layer of lipids, or “lipid bilayer,” that forms the structure, and a variety of embedded and attached proteins with highly specialized functions, including proteins that rapidly and selectively transport ions and molecules in and out of the cell.
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.
As the rise of antibiotic-resistant bacteria known as superbugs threatens public health, Oak Ridge National Laboratory’s Shuo Qian and Veerendra Sharma from the Bhaba Atomic Research Centre in India are using neutron scattering to study how an antibacterial peptide interacts with and fights harmful bacteria.
A team of scientists, led by University of Guelph professor John Dutcher, are using neutrons at ORNL’s Spallation Neutron Source to unlock the secrets of natural nanoparticles that could be used to improve medicines.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.
“Made in the USA.” That can now be said of the radioactive isotope molybdenum-99 (Mo-99), last made in the United States in the late 1980s. Its short-lived decay product, technetium-99m (Tc-99m), is the most widely used radioisotope in medical diagnostic imaging. Tc-99m is best known ...
A novel method developed at Oak Ridge National Laboratory creates supertough renewable plastic with improved manufacturability. Working with polylactic acid, a biobased plastic often used in packaging, textiles, biomedical implants and 3D printing, the research team added tiny amo...